Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2026-01-02 @ 4:37 AM
Study NCT ID:
NCT00819104
Status:
COMPLETED
Last Update Posted:
2009-09-09
First Post:
2009-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D4022L00006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Paurus M Irani; VP Medical & Regulatory
Old Organization:
AstraZeneca Pharmaceuticals India Ltd.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |